|
ZYPREXA
Zyprexa (Olanzapine), is prescribed to treat schizophrenia and bipolar mania, but has been linked to diabetes mellitus, hyperglycemia, pancreatitis and blood sugar disorders. Out of 288 reported diabetes cases in Zyprexa patients, 23 have been fatal.
A recent lawsuit found that prior to 2003, Eli Lilly did not properly disclose risks and known side effects of Zyprexa. Eli Lilly & Co. is accused of marketing Zyprexa as a safe and effective drug for psychotic disorders, while concealing the risks and side effects from doctors and patients.
Zyprexa's side effects are now considered such a risk that in 2002, both the Japanese Health and Welfare Ministry and the Great Britain Medicines Control Agency issued emergency warnings concerning Zyprexa and diabetes-related complications.
The FDA issued a label warning in 2003 for all atypical anti-psychotic drugs to include the risk of hyperglycemia. Currently, Zyprexa is still approved as safe and effective and patients should realize that it could be dangerous to stop taking the medication, especially abruptly, and should talk with their physicians to decide whether the benefits outweigh the risks of taking Zyprexa.
ZYPREXA NEWS
US District Court Judge rules that a class action lawsuit claiming that Eli Lilly & Co. marketed Zyprexa, an anti-psychotic drug, for purposes other than what was FDA approved, is allowed to proceed.(Jul-03-07) ZYPREXA: InjuryBoard.com
Eli Lilly annnounces second phase of settlements surrounding Zyprexa. By settling these cases, Lilly hopes to remove dark cloud over the drug and regain confidence of doctors and patients. (Jan-08-07) ZYPREXA: NewsInforno
|
 |
|